Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spontaneous abdominal bleeding associated with SARS-CoV-2 infection: causality or coincidence?
Sposato B, Croci L, Di Tomassi M, Puttini C, Olivieri C, Alessandri M, Ronchi MC, Donati E, Garcea A, Brazzi A, Migliorini MG, Chigiotti S, Nikiforakis N, Carli T, Canneti E, Strambio F, Cellini C, Nardangeli C, Allegri MP, Bianchi F, Bettini C, Perruzza M, Lanzarone N, Valentini L, Orselli P, Solari M, Cardaci S, Nofri M, Angeli G, Mangani F, Aloia E, Lanari A, Corridi M, Spargi G, Perrella A, Nencioni C. Sposato B, et al. Among authors: carli t. Acta Biomed. 2021 May 12;92(2):e2021199. doi: 10.23750/abm.v92i2.10142. Acta Biomed. 2021. PMID: 33988163 Free PMC article.
Mesalazine-induced multi-organ hypersensitivity.
Sposato B, Allegri MP, Riccardi MP, Chigiotti S, Nencioni C, Ricciardi B, Carli T, Cresti A, Perari MG, Migliorini MG, Toti M. Sposato B, et al. Among authors: carli t. Clin Drug Investig. 2010;30(6):413-7. doi: 10.1007/BF03256911. Clin Drug Investig. 2010. PMID: 20441247
Pharmacokinetic and safety of raltegravir in pregnancy.
Croci L, Trezzi M, Allegri MP, Carli T, Chigiotti S, Riccardi MP, Ricciardi B, Toti M, Nencioni C. Croci L, et al. Among authors: carli t. Eur J Clin Pharmacol. 2012 Aug;68(8):1231-2. doi: 10.1007/s00228-012-1250-5. Epub 2012 Mar 1. Eur J Clin Pharmacol. 2012. PMID: 22382989 No abstract available.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients.
Saladini F, Meini G, Bianco C, Monno L, Punzi G, Pecorari M, Borghi V, Di Pietro M, Filice G, Gismondo MR, Micheli V, Penco G, Carli T, De Luca A, Zazzi M; ARCA Collaborative Group. Saladini F, et al. Among authors: carli t. Clin Microbiol Infect. 2012 Oct;18(10):E428-30. doi: 10.1111/j.1469-0691.2012.03917.x. Epub 2012 Jun 21. Clin Microbiol Infect. 2012. PMID: 22716970 Free article.
Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy.
Franzetti M, Violin M, Casazza G, Meini G, Callegaro A, Corsi P, Maggiolo F, Pignataro AR, Paolucci S, Gianotti N, Francisci D, Rossotti R, Filice G, Carli T, Zazzi M, Balotta C. Franzetti M, et al. Among authors: carli t. Clin Microbiol Infect. 2012 Mar;18(3):E66-70. doi: 10.1111/j.1469-0691.2011.03740.x. Epub 2011 Dec 22. Clin Microbiol Infect. 2012. PMID: 22192680 Free article.
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice.
Prosperi MC, Zazzi M, Punzi G, Monno L, Colao G, Corsi P, Di Giambenedetto S, Meini G, Ghisetti V, Bonora S, Pecorari M, Gismondo MR, Bagnarelli P, Carli T, De Luca A; ARCA Collaborative Group. Prosperi MC, et al. Among authors: carli t. J Med Virol. 2010 Dec;82(12):1996-2003. doi: 10.1002/jmv.21927. J Med Virol. 2010. PMID: 20981785
299 results